Autoimmune Diseases  >>  Benlysta (belimumab) 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Benlysta (belimumab) / GSK
LBRA99, NCT00931086: Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol

No Longer Available
N/A
US
belimumab, BENLYSTA™ (belimumab), LymphoStat-B™
Human Genome Sciences Inc., a GSK Company, GlaxoSmithKline
Rheumatoid Arthritis
12/11
12/11
NCT03125486: Compassionate Use for Subcutaneous (SC) Belimumab

No Longer Available
N/A
US
SC belimumab 200 mg
GlaxoSmithKline
Systemic Lupus Erythematosus
 
 

Download Options